Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician?
The article discusses the results of randomized controlled trials and some observational studies that define the current understanding of the role of rivaroxaban in the prevention of cardioembolic complications in patients with atrial fibrillation (AF). According to the results of the randomized con...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Столичная издательская компания
2025-08-01
|
| Serier: | Рациональная фармакотерапия в кардиологии |
| Fag: | |
| Online adgang: | https://www.rpcardio.online/jour/article/view/3202 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|